ArticleInternational journal of cancer2025
Prevalence of and differences in participation restrictions among US cancer survivors.
Article in International journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Being diagnosed with cancer and undergoing cancer treatment can have detrimental effects on the physical and mental functioning of individuals. Understanding the prevalence and specific differences in functioning difficulties experienced by cancer survivors can enhance future research. In this cross-sectional study of self-reported functioning, we used a United States (US) nationally representative sample of adults aged ≥20 years (n = 7764) to assess for differences in the prevalence of participation restrictions based on the global standard Washington Group on Disability Statistics Short Set on Functioning. We measured differences using adjusted prevalence ratios (aPR) with 95% confidence intervals (CI), adjusted for sex, age, race and ethnicity, and educational attainment. Significant aPR differences were determined based on 95% CIs not including 1. Our final analytic sample included 908 cancer survivors (weighted prevalence, 9.1%; 95% CI, 8.4%-9.8%). We estimated that participation restrictions were 43.3% more common among cancer survivors than individuals with no cancer history (aPR, 1.433; 95% CI, 1.202-1.709). Among specific domains of functioning, cancer survivors experienced a significantly greater prevalence of difficulties with seeing, hearing, mobility, communicating, cognition, self-care, and upper-body functioning. Given the increasing number of cancer survivors in the US, it is crucial to develop interventions to reduce participation restrictions among this population and provide equal opportunities to fully engage in life without additional barriers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.